The Enterprise Value as of December 2024 (TTM) for DURECT Corporation (DRRX) is 34.76M

According to DURECT Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 34.76M. This represents a change of 6.82% compared to the average of 32.55M of the last 4 quarters.

DURECT Corporation (DRRX) Historical Enterprise Value (quarterly & annually)

How has DRRX Enterprise Value performed in the past?

The mean historical Enterprise Value of DURECT Corporation over the last ten years is 209.46M. The current 34.76M Enterprise Value has changed 1.56% with respect to the historical average. Over the past ten years (40 quarters), DRRX's Enterprise Value was at its highest in in the December 2019 quarter at 725.99M. The Enterprise Value was at its lowest in in the December 2023 quarter at 9.73M.

DURECT Corporation (DRRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of DURECT Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

DURECT Corporation (DRRX) Average Enterprise Value

How has DRRX Enterprise Value performed in the past?

The current Enterprise Value of DURECT Corporation (DRRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

DURECT Corporation (DRRX) Enterprise Value vs. Peers

How is DRRX’s Enterprise Value compared to its peers?

DURECT Corporation’s Enterprise Value is greater than Shuttle Pharmaceuticals Holdings, Inc. (3.23M), less than Mallinckrodt plc (2.67B), less than Organogenesis Holdings Inc. (413.14M), greater than Lucy Scientific Discovery Inc. (2.06M), less than Alimera Sciences, Inc. (362.58M), less than Alpha Teknova, Inc. (482.89M), greater than Agile Therapeutics, Inc. (7.87M), greater than Sonoma Pharmaceuticals, Inc. (-178066.00), greater than Eagle Pharmaceuticals, Inc. (19.21M), less than Lifecore Biomedical, Inc. (411.23M), greater than RedHill Biopharma Ltd. (3.70M), less than Taro Pharmaceutical Industries Ltd. (1.25B), less than Collegium Pharmaceutical, Inc. (1.77B), less than Neurocrine Biosciences, Inc. (13.73B), less than Deciphera Pharmaceuticals, Inc. (2.15B), less than Ironwood Pharmaceuticals, Inc. (1.26B), less than Alkermes plc (4.77B), less than Avadel Pharmaceuticals plc (959.14M), less than Aquestive Therapeutics, Inc. (279.92M), greater than Evoke Pharma, Inc. (942.42K), greater than Adamis Pharmaceuticals Corporation (-6593458674.00), greater than Guardion Health Sciences, Inc. (-10475955.00), greater than AcelRx Pharmaceuticals, Inc. (-587846.00),

Build a custom stock screener for DURECT Corporation (DRRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DURECT Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

DURECT Corporation (DRRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like DURECT Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.